Abdulraheem Alshareef

1.1k total citations
26 papers, 517 citations indexed

About

Abdulraheem Alshareef is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Abdulraheem Alshareef has authored 26 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 14 papers in Molecular Biology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Abdulraheem Alshareef's work include Cancer Cells and Metastasis (9 papers), Lymphoma Diagnosis and Treatment (5 papers) and Cancer Genomics and Diagnostics (4 papers). Abdulraheem Alshareef is often cited by papers focused on Cancer Cells and Metastasis (9 papers), Lymphoma Diagnosis and Treatment (5 papers) and Cancer Genomics and Diagnostics (4 papers). Abdulraheem Alshareef collaborates with scholars based in Canada, Saudi Arabia and China. Abdulraheem Alshareef's co-authors include Raymond Lai, Nidhi Gupta, Chengsheng Wu, En‐Min Li, Li‐Yan Xu, Jiwei Jiao, Haifeng Zhang, Haifeng Zhang, Afsaneh Lavasanifar and Fang Wu and has published in prestigious journals such as Blood, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Abdulraheem Alshareef

26 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abdulraheem Alshareef Canada 15 347 211 155 77 59 26 517
María Villa‐Morales Spain 12 274 0.8× 145 0.7× 133 0.9× 65 0.8× 39 0.7× 23 452
Shuyun Yang China 15 383 1.1× 139 0.7× 136 0.9× 48 0.6× 47 0.8× 18 490
Edmund Kwok–Kwan Tung Hong Kong 10 523 1.5× 134 0.6× 271 1.7× 76 1.0× 45 0.8× 11 682
Liangxian Cao United States 11 510 1.5× 277 1.3× 189 1.2× 35 0.5× 60 1.0× 17 694
Marco Crosariol United States 11 388 1.1× 229 1.1× 171 1.1× 62 0.8× 78 1.3× 15 607
Jorg Michels Canada 8 280 0.8× 151 0.7× 71 0.5× 47 0.6× 91 1.5× 14 451
Lalita Yadav India 5 213 0.6× 134 0.6× 153 1.0× 27 0.4× 35 0.6× 13 407
Janice M. Mehnert United States 8 303 0.9× 183 0.9× 58 0.4× 40 0.5× 36 0.6× 24 409
Silvia Pomella Italy 14 511 1.5× 129 0.6× 114 0.7× 30 0.4× 122 2.1× 29 644

Countries citing papers authored by Abdulraheem Alshareef

Since Specialization
Citations

This map shows the geographic impact of Abdulraheem Alshareef's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdulraheem Alshareef with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdulraheem Alshareef more than expected).

Fields of papers citing papers by Abdulraheem Alshareef

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdulraheem Alshareef. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdulraheem Alshareef. The network helps show where Abdulraheem Alshareef may publish in the future.

Co-authorship network of co-authors of Abdulraheem Alshareef

This figure shows the co-authorship network connecting the top 25 collaborators of Abdulraheem Alshareef. A scholar is included among the top collaborators of Abdulraheem Alshareef based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdulraheem Alshareef. Abdulraheem Alshareef is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alessy, Saleh A., et al.. (2024). Cancer Research Challenges and Potential Solutions in Saudi Arabia: A Qualitative Discussion Group Study. JCO Global Oncology. 10(10). e2300189–e2300189. 6 indexed citations
2.
Alshareef, Abdulraheem, et al.. (2021). Gene Methylation and Silencing of WIF1 Is a Frequent Genetic Abnormality in Mantle Cell Lymphoma. International Journal of Molecular Sciences. 22(2). 893–893. 1 indexed citations
3.
Alshareef, Abdulraheem, et al.. (2021). Prevalence and Factors Associated with Postpartum Depression among Women Attending Primary Health Care Centers in Al-Madina, Saudi Arabia. Psychology and Behavioral Sciences. 8(1). 18–24. 2 indexed citations
4.
Alshareef, Abdulraheem, et al.. (2021). Public Perceptions of Cupping Therapy (Hijama) and Whether It Will Be Chosen Over Donating Blood. Journal of Complementary and Alternative Medical Research. 30–35. 1 indexed citations
5.
Alshareef, Abdulraheem, et al.. (2021). Wet cupping (Hijama) positively and significantly impacted multiple hematological parameters. 9(2). 98–98. 2 indexed citations
6.
7.
Molavi, Ommoleila, Abdulraheem Alshareef, Qian Wang, et al.. (2018). Constitutive Activation of STAT3 in Myeloma Cells Cultured in a Three-Dimensional, Reconstructed Bone Marrow Model. Cancers. 10(6). 206–206. 20 indexed citations
8.
Gupta, Nidhi, Chengsheng Wu, Abdulraheem Alshareef, et al.. (2018). Phosphorylation of Sox2 at Threonine 116 is a Potential Marker to Identify a Subset of Breast Cancer Cells with High Tumorigenecity and Stem-Like Features. Cancers. 10(2). 41–41. 12 indexed citations
9.
10.
11.
Gupta, Nidhi, Karen Jung, Chengsheng Wu, et al.. (2017). High Myc expression and transcription activity underlies intra-tumoral heterogeneity in triple-negative breast cancer. Oncotarget. 8(17). 28101–28115. 23 indexed citations
12.
Garg, Shyam M., Mohammad Reza Vakili, Abdulraheem Alshareef, et al.. (2017). Micellar nano-carriers for the delivery of STAT3 dimerization inhibitors to melanoma. Drug Delivery and Translational Research. 7(4). 571–581. 16 indexed citations
13.
Alshareef, Abdulraheem, et al.. (2017). High expression of β-catenin contributes to the crizotinib resistant phenotype in the stem-like cell population in neuroblastoma. Scientific Reports. 7(1). 16863–16863. 8 indexed citations
14.
Zhang, Haifeng, Abdulraheem Alshareef, Chengsheng Wu, et al.. (2016). miR-200b induces cell cycle arrest and represses cell growth in esophageal squamous cell carcinoma. Carcinogenesis. 37(9). 858–869. 33 indexed citations
15.
Alshareef, Abdulraheem, Haifeng Zhang, Chengsheng Wu, et al.. (2016). The use of cellular thermal shift assay (CETSA) to study Crizotinib resistance in ALK-expressing human cancers. Scientific Reports. 6(1). 33710–33710. 36 indexed citations
16.
Wu, Chengsheng, Haifeng Zhang, Nidhi Gupta, et al.. (2016). A positive feedback loop involving the Wnt/β-catenin/MYC/Sox2 axis defines a highly tumorigenic cell subpopulation in ALK-positive anaplastic large cell lymphoma. Journal of Hematology & Oncology. 9(1). 120–120. 27 indexed citations
17.
Zhang, Hai-Feng, Ye Chen, Chengsheng Wu, et al.. (2015). The Opposing Function of STAT3 as an Oncoprotein and Tumor Suppressor Is Dictated by the Expression Status of STAT3β in Esophageal Squamous Cell Carcinoma. Clinical Cancer Research. 22(3). 691–703. 45 indexed citations
18.
Gupta, Nidhi, Karen Jung, Abdulraheem Alshareef, et al.. (2015). DDX17 (P72), a Sox2 binding partner, promotes stem-like features conferred by Sox2 in a small cell population in estrogen receptor-positive breast cancer. Cellular Signalling. 28(2). 42–50. 27 indexed citations
19.
Jung, Karen, Peng Wang, Nidhi Gupta, et al.. (2014). Profiling gene promoter occupancy of Sox2 in two phenotypically distinct breast cancer cell subsets using chromatin immunoprecipitation and genome-wide promoter microarrays. Breast Cancer Research. 16(6). 470–470. 14 indexed citations
20.
Alshareef, Abdulraheem, et al.. (2012). Disheveled proteins promote cell growth and tumorigenicity in ALK-positive anaplastic large cell lymphoma. Cellular Signalling. 25(1). 295–307. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by María Villa‐Morales Breakdown of academic impact, for papers by Shuyun Yang Breakdown of academic impact, for papers by Edmund Kwok–Kwan Tung Breakdown of academic impact, for papers by Liangxian Cao Breakdown of academic impact, for papers by Marco Crosariol Breakdown of academic impact, for papers by Jorg Michels Breakdown of academic impact, for papers by Lalita Yadav Breakdown of academic impact, for papers by Janice M. Mehnert Breakdown of academic impact, for papers by Silvia Pomella
Rankless by CCL
2026